Therapies for inherited skin fragility disorders

Area of Science:

• Dermatology
• Genetics
• Molecular Biology

Background:

• Inherited skin fragility encompasses genetic disorders causing mechanical blistering and erosions due to impaired skin adhesion.
• Mutations in genes encoding adhesion proteins lead to compromised intra-epidermal or dermal-epidermal integrity.
• The largely understood molecular pathology makes these disorders a model for therapeutic development.

Purpose of the Study:

• To review the progress and challenges in developing curative treatments for inherited skin fragility.
• To discuss the potential of gene, cell, and protein therapies.
• To highlight alternative strategies for symptom management and complication prevention.

Main Methods:

• Review of current research on molecular pathology of inherited skin fragility.
• Analysis of advancements in gene, cell, and protein-based therapeutic approaches.
• Exploration of supportive strategies including protein stabilization and modulation of apoptosis, inflammation, and scarring.

Main Results:

• Significant progress has been made in gene, cell, and protein therapies for inherited skin fragility.
• No single therapeutic strategy can address all molecular and clinical aspects of these disorders.
• Curative treatments face challenges in clinical accessibility.

Conclusions:

• While curative therapies are advancing, they require further development for widespread clinical application.
• Alternative strategies are crucial for alleviating symptoms and preventing complications until curative treatments are available.
• A multi-faceted approach combining advanced therapies with supportive care is essential for managing inherited skin fragility.